Lumida
/ASPI
⌘K
ASP Isotopes Inc

ASP Isotopes Inc

ASPI
$3.31USD-7.80%-0.28 today

MARKET CAP

507.5M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $4

52W RANGE

$3
$14

AI Summary

Stalk
TrimMedium

ASPI remains in a Stage 4 decline with lower highs and lower lows, trading below all key EMAs and near multi-month lows. Extreme oversold readings caution against immediate selling without a relief rally. We will await a pullback into the declining EMA band as a structurally appropriate supply zone before trimming positions.

  • Revenue 2025: $23.8M (+480% YoY) driven by radiopharmacy
  • Cash & equivalents $333M (liquidity score 1.05) funds expansions
  • YTD net loss $34.9M driven by 84% higher Opex
Full analysis →

Buying

6

institutions

Selling

4

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
BI

Blackrock, Inc.

Q2 2026

BUY9.22 M57.33 M+889.05 K+55.8%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL1.71 M10.65 M+-929.01 K-8.8%0.00%
MG

Man Group Plc

Q2 2026

BUYNEW828.38 K5.15 M+828.38 K+0.0%0.01%
JC

Jpmorgan Chase & Co

Q2 2026

SELL241.05 K1.50 M+-32.41 K+29.9%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY164.26 K1.02 M+120.16 K+424.1%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY78.00 K344.37 K+39.00 K+65.2%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUY39.58 K246.16 K+22.11 K+218.9%0.00%
AC

Aqr Capital Management LLC

Q2 2026

SELL13.59 K84.52 K+-10.21 K-19.6%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

SELL11.64 K72.38 K+-64.89 K-78.6%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

BUY6.25 K38.84 K+1.23 K+75.1%0.00%